Mutations in the ras proto-oncogene: clues to etiology and molecular pathogenesis of mouse liver tumors
Authors:
- 1 August 1995
- journal article
- review article
- Published by Elsevier in Toxicology
- Vol. 101 (3) , 125-156
Abstract
No abstract availableKeywords
This publication has 70 references indexed in Scilit:
- Data Analysis: Statistical Analysis and Use of Historical Control DataRegulatory Toxicology and Pharmacology, 1995
- Multiple Loci Affect Genetic Predisposition to Hepatocarcinogenesis in MiceGenomics, 1994
- ras mutations in 2‐amino‐3‐methylimidazo‐[4,5‐f]quinoline—induced tumors in the CDF1 mouseMolecular Carcinogenesis, 1993
- Murine p53 intron sequences 5–8 and their use in polymerase chain reaction/direct sequencing analysis of p53 mutations in CD‐1 mouse liver and lung tumorsMolecular Carcinogenesis, 1992
- Role of mutations at codon 61 of the c‐Ha‐ras gene during diethylnitrosamine‐induced hepatocarcinogenesis in C3H/He miceMolecular Carcinogenesis, 1992
- p53 mutations are absent from carcinogen‐induced mouse liver tumors but occur in cell lines established from these tumorsMolecular Carcinogenesis, 1992
- Mutations at codon 61 of the Ha‐ras proto‐oncogene in precancerous liver lesions of the B6C3F1 mouseMolecular Carcinogenesis, 1989
- Genetic susceptibility to murine hepatocarcinogenesis is associated with high growth rate of NDEA-initiated hepatocytesJournal of Cancer Research and Clinical Oncology, 1987
- Activation of a Cellular Proto-Oncogene in Spontaneous Liver Tumor Tissue of the B6C3F1 Mouse1987
- The susceptibility of various strains of neonatal mice to the carcinogenic effects of 9,10-dimethyl-1,2-benzanthraceneEuropean Journal of Cancer (1965), 1968